For research use only
| Cat No. | ABC-SC0028 |
| Product Type | Animal Adult Stem Cells |
| Cell Type | Stem Cell |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Prostate |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Mouse Retinal Stem Cells; Frozen Vial and Plated cells are available.
HighQC™ Mouse Retinal Stem Cells are isolated from the ciliary marginal zone (CMZ) of neonatal or young adult mouse eyes, a region known to harbor multipotent retinal progenitor cells. These stem cells exhibit a bipolar or spindle-shaped morphology and grow as adherent monolayers under defined culture conditions. They express stem/progenitor markers such as Sox2, Pax-6, Nestin, CD117, B Tubulin III, GFAP. The cells display self-renewal capacity in vitro and retain the potential to differentiate into multiple retinal lineages, including photoreceptors, Müller glia, and retinal ganglion cells, under appropriate inductive conditions. HighQC™ Mouse Retinal Stem Cells offer a powerful system for studying retinal development, degeneration, and regenerative strategies. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ Mouse Retinal Stem Cell, Mouse Retinal Progenitor Cells, mRSCs |
| Species | Mouse |
| Cat.No | ABC-SC0028 |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Prostate |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Animal Adult Stem Cells |
HighQC™ Mouse Retinal Stem Cells are a valuable tool for retinal disease modeling, cell-based replacement therapies, and high-throughput screening of neuroprotective compounds. They serve as an in vitro platform to investigate cellular and molecular mechanisms underlying photoreceptor degeneration, retinitis pigmentosa, or age-related macular degeneration (AMD). Their responsiveness to differentiation signals also supports gene therapy validation and neuroregeneration studies, and ophthalmic drug development.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).